RHENMAN & PARTNERS ASSET MANAGEMENT AB – Sangamo Therapeutics, Inc. Transaction History
RHENMAN & PARTNERS ASSET MANAGEMENT AB portfolio value:
$3.6M
portfolio value
RHENMAN & PARTNERS ASSET MANAGEMENT AB quarter portfolio value change:
+18.36%
quarter
Sangamo Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +17.14% | 120K shares | 702K | $4.9 | 820K |
| Q2 2022 | share | Decrease | -8.07% | -61.42K shares | -1.52M | $4.14 | 700K |
| Q1 2022 | share | Decrease | -0.47% | -3.57K shares | -1.55M | $5.81 | 761.42K |
| Q4 2021 | share | 0.00% | 0 shares | -918K | $7.81 | 765K | |
| Q3 2021 | share | 0.00% | 0 shares | -2.26M | $9.01 | 765K | |
| Q2 2021 | share | 0.00% | 0 shares | -428K | $11.97 | 765K | |
| Q1 2021 | share | Decrease | -6.92% | -56.88K shares | -3.24M | $12.53 | 765K |
| Q4 2020 | share | Increase | +21.76% | 146.88K shares | 6.44M | $15.61 | 821.88K |
| Q3 2020 | share | 0.00% | 0 shares | 331K | $9.45 | 675K | |
| Q2 2020 | share | Decrease | -3.57% | -25K shares | 1.58M | $8.96 | 675K |
| Q1 2020 | share | 0.00% | 0 shares | -1.4M | $6.37 | 700K | |
| Q4 2019 | share | Decrease | -4.74% | -34.81K shares | -791K | $8.37 | 700K |
| Q3 2019 | share | Decrease | -7.45% | -59.14K shares | -1.90M | $9.05 | 734.81K |
| Q2 2019 | share | Decrease | -5.92% | -50K shares | 500K | $10.77 | 793.95K |
| Q1 2019 | share | Decrease | -23.55% | -260K shares | -4.62M | $9.54 | 843.95K |
| Q4 2018 | share | Decrease | -7.80% | -93.4K shares | -7.62M | $11.48 | 1.10M |
| Q3 2018 | share | Increase | +13.82% | 145.42K shares | 5.35M | $16.95 | 1.19M |
| Q2 2018 | share | Increase | +311.24% | 796.14K shares | 10.07M | $14.2 | 1.05M |
| Q1 2018 | share | 0.00% | 0 shares | 665K | $19 | 255.79K | |
| Q4 2017 | share | Increase | 0.00% | 255.79K shares | 4.19M | $16.4 | 255.79K |